Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Labo Line Oy
OY
Active
Y-tunnus 0918872-4
Karjalankatu 2, 00520
Helsinki
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 1993 · 33 years old
— employees
Share
Finland
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Labo Line Oy
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
EUR millions
7M
6M
4M
2M
0M
2021: 4M
4M
2021
2022: 5M (+25% vs 2021)
5M
+25%
2022
2023: 6M (+20% vs 2022)
6M
+20%
2023
2024: 5M (-17% vs 2023)
5M
-17%
2024
2025: 5M (0% vs 2024)
5M
0%
2025
EBITDA
EUR millions
14M
10M
7M
3M
0M
2021: 1M
1M
2021
2022: 1M (0% vs 2021)
1M
0%
2022
2023: 11M (+1000% vs 2022)
11M
+1000%
2023
2024: 10M (-9% vs 2023)
10M
-9%
2024
2025: 10M (0% vs 2024)
10M
0%
2025
Income statement
EUR thousands
Item
2025
2024
2023
2022
2021
Revenue
5 099
4 948
5 755
4 711
4 108
Staff expenses
944
1 072
819
−725
−712
EBITDA
9 831
9 699
10 773
504
536
Depreciation & amort.
26
25
29
−37
−44
EBIT
434
262
817
467
492
Net financials
—
—
−9
−5
−7
Profit before tax
429
251
808
462
485
Tax
86
51
162
93
97
Net profit
343
200
646
369
388
Balance sheet
EUR thousands
Item
2025
2024
2023
2022
2021
Total assets
4 386
3 335
3 525
3 030
2 706
Equity
2 681
2 541
2 544
2 063
1 954
Long-term debt
33
25
74
92
148
Short-term debt
1 673
768
907
874
603
Total debt
1 705
794
981
966
751
Financial ratios
5-year trend
EBITDA margin
192,8 %
This company
15,8 %
Market median
This company
Market median
>999% above market
2021
2025
Equity ratio
61,1 %
This company
38,2 %
Market median
This company
Market median
60% above market
2021
2025
Return on equity
12,8 %
This company
18,4 %
Market median
This company
Market median
30% below market
2021
2025
Net profit margin
6,7 %
This company
8,1 %
Market median
This company
Market median
17% below market
2021
2025
Asset turnover
1,16×
This company
1,12×
Market median
This company
Market median
4% above market
2021
2025
Debt / equity
0,64×
This company
0,62×
Market median
This company
Market median
3% above market
2021
2025
Annual reports & filings
Annual report 2025
Filed via PRH / YTJ · Period 2024-04-01 – 2025-03-31
View
PDF
Annual report 2024
Filed via PRH / YTJ · Period 2023-04-01 – 2024-03-31
View
PDF
Annual report 2023
Filed via PRH / YTJ · Period 2022-04-01 – 2023-03-31
View
PDF
Annual report 2022
Filed via PRH / YTJ · Period 2021-04-01 – 2022-03-31
View
PDF
Annual report 2021
Filed via PRH / YTJ · Period 2020-04-01 – 2021-03-31
View
PDF
More on Labo Line Oy
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
